
TRIPLOIDIES IN FIRST AND SECOND TRIMESTERS
OF PREGNANCIES IN TURKEY Yilmaz Z1, Sahin FI1,*, Tarim E2, Kuscu E2 *Corresponding Author: Yilmaz Z1, Sahin FI1,*, Tarim E2, Kuscu E2*Corresponding Author: Professor Dr. Feride Iffet Sahin, Department of Medical Genetics,
Faculty of Medicine, Baskent University, Kubilay Sokak No: 36 Maltepe, 06570 Ankara, Turkey;
Tel.: +90-312-2324400/138; Fax: +90-312-2319134; E-mail: feridesahin@hotmail.com page: 71
|
MATERIALS AND METHODS
A total of 1,114 amniotic fluid samples and 75 abortion samples that were karyotyped between January 2002 and December 2005 were included. Amniocentesis was made between 15 and 22 weeks of gestation due to an increased risk of chromosomal abnormalities in maternal serum screening tests that were performed in the second trimester. Cytogenetic analysis was suggested whenever the combined risk was above 1/250 for Down’s syndrome and/or combined risk above 1/100 for trisomy 18 [7].
Both extra embryonic tissue and amniotic fluid tissue cultures were set up in two separate tissue culture flasks (Greiner, Frickenhausen, Germany) with Amniomed culture medium (Biochrom, Berlin, Germany). On the 7th day of culture, the medium was changed, and when an appropriate number of mitoses was observed, the cells were harvested [8]. Chromosomes were Giemsa-trypsin (GTG) banded and at least 20 metaphases were analyzed from each sample.
Genetic counseling was given in two sessions to couples. During the first session, couples were informed about the suspicious genetic abnormality and genetic diagnosis methods after pedigree analysis. When karyotype analyses were completed and triploidy was detected, the parents were informed about the triploidy and the recurrence risks for individual karyotype findings during the second genetic counseling session. Detailed USG examination was performed in every pregnancy at 18 or 19 weeks of gestation. Pathological examination was performed in all abort ed or terminated fetuses.
|
|
|
|



 |
Number 27 VOL. 27 (2), 2024 |
Number 27 VOL. 27 (1), 2024 |
Number 26 Number 26 VOL. 26(2), 2023 All in one |
Number 26 VOL. 26(2), 2023 |
Number 26 VOL. 26, 2023 Supplement |
Number 26 VOL. 26(1), 2023 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|